Patients with Wilson disease are at risk of osteoporosis and osteopenia, particularly older, male patients and those with skeletal symptoms.

Nipocalimab is a fully human, IgG1, high-affinity monoclonal antibody that blocks placental IgG transfer and reduces levels of circulating maternal IgG.

Özge’s background is in research; she holds a MSc. in Molecular Genetics from the University of Leicester and a PhD. in Developmental Biology from the University of London. Özge worked as a bench ...